NCT02264535View on ClinicalTrials.gov

A Pilot Study for Ginkgolides Meglumine Injection Skin Testing.

PHASE4CompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

November 30, 2014

Conditions
Allergy
Interventions
DRUG

0.1mg/ml Ginkgolides Meglumine Injection

DRUG

1mg/ml Ginkgolides Meglumine Injection

DRUG

5mg/ml Ginkgolides Meglumine Injection

Trial Locations (1)

300150

Second Affiliated Hospital of Tianjin University of TCM, Tianjin

Sponsors
All Listed Sponsors
collaborator

Beijing Bionovo Medicine Development Co., Ltd.

OTHER

lead

Jiangsu Kanion Pharmaceutical Co., Ltd

INDUSTRY

NCT02264535 - A Pilot Study for Ginkgolides Meglumine Injection Skin Testing. | Biotech Hunter | Biotech Hunter